Pages that link to "Q74405501"
Jump to navigation
Jump to search
The following pages link to Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers (Q74405501):
Displaying 50 items.
- BRCA1 supports XIST RNA concentration on the inactive X chromosome (Q24316340) (← links)
- BRCAness: finding the Achilles heel in ovarian cancer (Q24630872) (← links)
- Association of BRCA1 with the inactive X chromosome and XIST RNA (Q24675531) (← links)
- Ovarian surface epithelium: family history and early events in ovarian cancer (Q24791495) (← links)
- BRCA1-mediated repression of select X chromosome genes (Q24796376) (← links)
- Molecular tumor profiling: translating genomic insights into clinical advances (Q24797250) (← links)
- Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery (Q24798742) (← links)
- Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients (Q24816153) (← links)
- Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery (Q27025623) (← links)
- PARP Inhibitor Treatment in Ovarian and Breast Cancer (Q28741688) (← links)
- Hallmarks of 'BRCAness' in sporadic cancers (Q29618825) (← links)
- Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma (Q30430198) (← links)
- PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma (Q30434644) (← links)
- Regulation of clustered gene expression by cofactor of BRCA1 (COBRA1) in breast cancer cells (Q30441905) (← links)
- Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells (Q30444129) (← links)
- Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease (Q30448232) (← links)
- Coexpression analysis of human genes across many microarray data sets (Q30936126) (← links)
- BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. (Q30992379) (← links)
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities (Q33315604) (← links)
- Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer (Q33511864) (← links)
- Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations (Q33584262) (← links)
- The biology of ovarian cancer: new opportunities for translation (Q33622369) (← links)
- Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation (Q33693203) (← links)
- Identification of a Preneoplastic Gene Expression Profile in Tubal Epithelium of BRCA1 Mutation Carriers (Q33775466) (← links)
- Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. (Q34049228) (← links)
- BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma (Q34134454) (← links)
- BRCA1 and BRCA2: 1994 and beyond (Q34345297) (← links)
- Molecular portraits and the family tree of cancer (Q35010198) (← links)
- The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. (Q35026396) (← links)
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers (Q35049524) (← links)
- Classification of cancers by expression profiling (Q35062466) (← links)
- Differential gene expression in ovarian carcinoma: identification of potential biomarkers (Q35103006) (← links)
- How to improve postgenomic knowledge discovery using imputation (Q35209081) (← links)
- Oncogenic pathways implicated in ovarian epithelial cancer (Q35213223) (← links)
- Microenvironment and pathogenesis of epithelial ovarian cancer (Q35419057) (← links)
- The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy (Q35534509) (← links)
- X-chromosome genetics and human cancer (Q35852318) (← links)
- The genetic epidemiology of breast cancer genes (Q35959353) (← links)
- Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy (Q35985492) (← links)
- Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report (Q36108160) (← links)
- BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. (Q36189172) (← links)
- Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients (Q36446316) (← links)
- BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study (Q36747377) (← links)
- Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer (Q36763684) (← links)
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study (Q36768921) (← links)
- Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network (Q37120275) (← links)
- Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer. (Q37140001) (← links)
- Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families. (Q37148659) (← links)
- Classification of ovarian cancer: a genomic analysis. (Q37188831) (← links)
- Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. (Q37270601) (← links)